To deepen the integration of scientific and technological innovation with industrial innovation and promote the conversion and implementation of high-value technological achievements in Jinan City, on 11 June 2025, the 2025 High-Value Technological Achievements Project City Conversion Roadshow Matchmaking Conference (Shandong Provincial Laboratory Special Session) was held in the Roadshow Hall on the 2nd floor of the Shandong Science and Technology Market, hosted by the Shandong Provincial Institute of Innovative Development and the Jinan Municipal Science and Technology Bureau. As one of the co-organisers, the Jinan Microecological Biomedicine Shandong Laboratory participated in the roadshow with multiple innovative achievements, contributing to the establishment of a new mechanism for collaborative development among ‘laboratories, enterprises, and industrial chains.’
The event was hosted by Zhang Gensheng, Chief Engineer and Senior Researcher of the Jinan Municipal Science and Technology Bureau. Wang Fuling, Member of the Party Leadership Group and Deputy Director of the Jinan Municipal Science and Technology Bureau, and Yu Hao, Member of the Party Leadership Group and Deputy Director of the Shandong Provincial Institute of Innovation and Development, delivered opening remarks. Professor Jiang Chunping, Deputy Director of the Laboratory, led the technical achievement research and development team to participate in the roadshow exhibition.
Professor Jiang Chunping focused on the field of biomedicine and health, introducing the laboratory's strategic positioning, research layout, and talent team, and highlighting the latest breakthroughs in microecological intervention and innovative drug development.
During the project signing ceremony, the laboratory signed a ‘Strategic Cooperation Agreement on Medical Experimental Animal Technology Innovation and Joint Research’ with Shandong Aimeng Biotechnology Co., Ltd. and a ‘Strategic Cooperation Agreement on Testing and Inspection Technology Collaborative Innovation and Market Expansion’ with Jinan Yifa Medical Testing Laboratory Co., Ltd. This signing further extended the laboratory's industry-academia-research cooperation chain and laid a solid cooperative foundation for the large-scale application of future technological achievements.
During the roadshow, the laboratory highlighted the following three innovative projects:
First, the novel oncolytic virus candidate drug ADV alpha for pan-cancer therapy. This project, based on cutting-edge oncolytic virus technology, has developed a candidate drug with broad-spectrum antitumour potential targeting various solid tumours, offering a new strategy for cancer treatment; second, the uric acid-lowering composite probiotic solid formulation ‘Lixianning,’ developed using microecological regulation technology, which effectively reduces blood uric acid levels, providing a safe, long-term intervention solutions for patients with hyperuricemia and gout; third, the ‘Jiwei® Gynaecological Antiseptic Gel’ series of products, developed based on the theory of microecological balance, which regulate the microbial flora and inhibit pathogenic microorganisms, are dedicated to technological transformation in the field of women's health.
This roadshow event represents a significant opportunity for the laboratory to facilitate the integration of research and industry. By showcasing innovative achievements, the laboratory will further deepen collaborative partnerships with enterprises and the industrial chain, continue to focus on cutting-edge technological breakthroughs in the biomedical and health sectors, accelerate the commercialisation of technologies, and inject new momentum into the development of Jinan's biopharmaceutical industry.
